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Original ArticleLip Dose Challenges in Food Allergy: Current
Practice and Diagnostic Utility in the United
KingdomMarta Vazquez-Ortiz, MD, PhDa,b,*, Siân Ludman, MBBSc,*, Antony Aston, MBBSb, Lee Noimark, MBBSd, and
Paul J. Turner, FRACP, PhDa,b,e London, United Kingdom; and Sydney, New South Wales, AustraliaWhat is already known about this topic? Lip dose challenges (LDCs) may be common in clinical practice.
What does this article add to our knowledge? Most UK allergy centers include a lip dose as part of routine food
challenge, with a wide variation in performance and interpretation, which impacts on test reproducibility and validity. The
diagnostic utility of LDCs is limited.
How does this study impact current management guidelines? LDC is unlikely to confer any advantage if incorporated
into routine oral food challenges, and may be associated with false positives and systemic reactions. Clinical guidelines
should actively caution against the use of LDC in the diagnosis of food allergy.BACKGROUND: Lip dose challenges (LDCs) are often
performed as an initial step before oral food challenges (OFCs).
However, guidance on how to perform and interpret LDCs is
unclear, and data are lacking regarding the diagnostic accuracy
of LDCs.
OBJECTIVE: To investigate current practice with respect to
LDCs among UK allergy health care professionals, and to
evaluate the diagnostic utility of LDCs in children undergoing
OFCs for IgE-mediated food allergy.
METHODS: We used an electronic survey to assess the use of
LDCs by UK Allergy clinics. Separately, we prospectively
recruited children undergoing “low-risk” OFCs for suspected
IgE-mediated food allergy from 2 large specialist allergy units
in London. LDC was performed 30 minutes before the OFC,
by applying the food to the inner lip for 30 seconds.
Objective symptoms were considered a positive outcome. All
patients subsequently proceeded to OFC regardless of LDC
outcome, and outcome assessed according to PRACTALL
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representing 67% of registered pediatric allergy clinics in the
United Kingdom. Eighty percent of respondents (representing
81% of responding centers) included LDC as the ﬁrst step of
OFC in routine clinical practice. There was a wide variation in
both how LDCs were performed and interpreted, with one-third
not proceeding to OFC if LDC resulted in subjective symptoms.
In the prospective study, 198 children (mean age, 7 years) with
conclusive OFCs were included. Foods tested were tree nuts
(30%), peanut (16.6%), egg (16%), ﬁsh (10.5%), milk (6%),
shrimp (4%), and other (16.9%). There were 12 positive LDCs
(1 of which triggered systemic symptoms: generalized urticaria)
and 31 positive OFCs. Two children with positive LDCs went on
to have a negative diagnostic OFC. Sensitivity of LDC was 32%,
speciﬁcity 98%, with a false-negative rate of 68%.
CONCLUSIONS: Most UK allergy clinics included LDC as an
initial step during OFC, despite a wide variation in how LDCs
are performed and interpreted, which raises major concerns
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INTRODUCTION
Oral food challenges (OFCs) remain the criterion standard for
the diagnosis of IgE-mediated food allergy.1,2 Anecdotally, lip
dose challenges (LDCs) (also referred to as labial challenges in the
literature) appear to be commonplace in clinical practice in some
countries, although guidance on how to perform and interpret
LDCs is lacking. Monteret-Vautrin et al3 suggested an applica-
tion time between 2 seconds and 10 minutes, a wide range that is
likely to have an impact on outcome. Likewise, very subtle
changes such as “smoothing of the lip” could be considered
sufﬁcient to indicate a positive LDC,3 which may lead to
subjectivity in interpretation. There is a lack of data as to how
the LDC correlates to the OFC outcome: previous studies
assumed a diagnosis of food allergy on the basis of a positive
LDC, without progressing to formal OFC to conﬁrm the diag-
nosis.4,5 Hourihane et al6 reported that a subset of patients with
suspected peanut allergy and a positive LDC passed a subsequent
OFC, raising a concern about the risk of false-positive LDCs.
Accordingly, LDCs are not recommended in some guidelines on
food allergy diagnosis or OFCs,2,7 but are included as a ﬁrst step
in other protocols.8,9
Given this variation in both practice and interpretation, we
undertook a 2-phase study: ﬁrst, to systematically assess the use of
LDC, and investigate current practice and perceptions of LDC
among health care professionals working in Pediatric Allergy in the
UnitedKingdom; second, to evaluate the diagnostic utility of LDC
compared with OFC outcomes in children undergoing diagnostic
food challenge for suspected IgE-mediated food allergy.
METHODS
Survey of health care professionals
We undertook a web-based survey among health care pro-
fessionals who were members of the Paediatric Allergy Interest
Group of the British Society for Allergy and Clinical Immunology.
The content of the questionnaire is presented in Table E1 in this
article’s Online Repository at www.jaci-inpractice.org. Brieﬂy, it
covered respondents’ demographic characteristics, professional
experience, and perception of LDC utility in clinical practice. Also,
respondents were asked how they would perform LDC for a ﬂuid,
semisolid, and solid food (ie, milk, peanut butter, and cashew,
respectively) and how they would interpret the LDC outcome
(ie, whether a given manifestation would be considered a positiveoutcome and whether food allergy diagnosis would be assumed with
no need for further OFC).
Prospective assessment of false positives/negatives
associated with LDC
In the second phase of the study, children undergoing open OFC
for suspected IgE-mediated food allergy were recruited prospectively
from 2 large specialist allergy units in London (St Mary’s Hospital
[Imperial College Healthcare NHS Trust] and the Royal London
Hospital [Barts Health NHS Trust]), from June to December 2015.
Clinical data were registered including age, atopic dermatitis, other
food allergies, food tested at OFC, skin prick test result to the tested
food, and whether the suspected diagnosis was based on previous
reaction or sensitization only. Skin prick testing was performed ac-
cording to standard guidelines, with histamine 10 mg/mL as a
positive control.10 OFC were performed because of indeterminate
allergic status—either a reducing skin prick test in the context of
possible resolution, level of sensitization less than 95% positive
predictive values, or more than 95% predictive value but with an
absence of previous reaction or with evidence of possible tolerance.
LDC was performed in all subjects 30 minutes before OFC. A
small pea-sized amount of the allergen in question was applied to the
border of the inner and outer lip and the patient observed for 30
minutes; we chose this time interval to be consistent with the dosing
interval used for OFC, although existing LDC protocols use a 20-
minute interval.8,9 We used a liquid/paste (eg, nut butter) for
application; where this was not possible due to the nature of the
food, the lip was gently rubbed with the allergen in question for 10
seconds. The following objective symptoms following LDC were
considered a positive outcome: erythema, urticaria, and/or angioe-
dema at the application site or systemic skin, gastrointestinal,
respiratory, or cardiovascular symptoms. Subjective symptoms were
not used as indicative of a positive LDC.
All subjects then proceeded to open OFC regardless of the LDC
outcome, except where the LDC resulted in a systemic reaction that
would qualify as a positive result in an OFC. Children were fed incre-
mental doses of the allergen in question, up to a top dose of 3 g protein
equivalent, at 30-minute intervals. The challenge was halted at onset of
objective clinical symptoms, in line with PRACTALL criteria,1 unless
consent was withdrawn previously. Childrenwere observed for a further
2 hours following the last dose. Each OFC was documented on a
standardized proforma, and outcome reviewed independently by 2
authors (M.V.O., P.J.T.) according to the PRACTALL consensus.1
Children with inconclusive OFC (eg, OFC halted before reaching
PRACTALL stopping criteria) were excluded from analysis.
LDC was already included in the existing clinical protocols at
both sites; thus, the study involving patients was considered a clinical
service evaluation. Our local Research Ethics Committee advised
that this did not require ethical approval, because no changes were
required in relation to routine practice.
Data analysis
The OFC outcome was used as the reference parameter to
calculate the diagnostic performance of the LDC, together with 95%
CIs according to the efﬁcient-score method (corrected for continu-
ity) outlined by Newcombe.11 Given our interest in assessing the
risk of false positives associated with LDC, we used the method of
Carley et al12 to determine that a sample size of approximately 220
would be sufﬁcient to allow us to estimate the speciﬁcity of LDC
within 10% of that for OFC with probability of ﬁnding a false-
positive result at 5% or less. Fisher Exact test was used for
FIGURE 1. Technique of application for fluid (milk), semisolid (peanut butter), and solid food (cashew) for LDC, as reported by
respondents.
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and negative LDC, except for continuous variables for which Mann-
Whitney U test was used. PASW Statistics 18 (SPSS Inc, Chicago,
Ill) was used for analysis.RESULTS
Perception and use of LDCs by health care
professionals in the United Kingdom
One hundred forty-seven respondents completed the ques-
tionnaire, which represented 67% (53 of 79) of British Societyfor Allergy and Clinical Immunologyeregistered pediatric allergy
clinics in the United Kingdom. Of these respondents, 88 (60%)
were doctors, 51 (32%) specialist nurses, and 8 (5%) dietitians.
The vast majority worked in specialist allergy clinics and district
general hospitals (48% and 50%, respectively), with 67%
working exclusively in the pediatric setting. Overall responses are
presented in Table E1.
Most respondents (71%, 102 of 147) reported that in their
opinion, LDCs were a useful ﬁrst step when performing an OFC.
Eighty percent (117 of 147), representing 81% of responding
centers, included LDC as a ﬁrst step in an OFC in routine clinical
TABLE I. Interpretation of subjective and objective symptoms at
LDC
Symptom
STOP the
challenge
CONTINUE with
oral challenge
Oral pruritus or itchy lip 17% 83%
Erythema at the site of application 31% 69%
Urticaria and/or local angioedema
at the site of application
88% 13%
Urticaria/angioedema on face, but
remote from the site of
application
93% 7%
Urticaria elsewhere (not on face) 93% 7%
TABLE II. Patient characteristics undergoing LDC/OFC (n ¼ 220)
Characteristic Value
Age (y), median (range) 6.0 (0.4-18)
Skin prick test (mm), median, (range) 2 (0-10)
 Sensitization 2 mm 148 (67)
Atopic eczema 80 (36)
Other documented food allergies 207 (94)
Food being tested at OFC:
 Tree nuts 66 (30)
B Hazelnut 21 (10)
B Almond 14 (6)
B Cashew 12 (5)
B Walnut 11 (5)
B Other 9 (4)
 Peanuts 36 (16)
 Egg 35 (16)
 Fish 23 (10)
 Cow’s milk 13 (6)
 Prawn/shrimp 9 (4)
 Other 37 (17)
Previous reaction to food being tested 71 (32)
Values are n (%) unless otherwise indicated.
TABLE III. Diagnostic properties of the LDC in relation to OFC
outcome in 198 children with suspected IgE-mediated food
allergy
Diagnostic properties of LDC Value
True negative (no. of patients) 165
True positive (no. of patients) 10
False negative (no. of patients) 21
False positive (no. of patients) 2
Speciﬁcity (%, 95% CI) 98% (95.3-99.8)
Sensitivity (%, 95% CI) 32% (17.3-51.5)
Positive predictive value (%, 95% CI) 83% (50.9-97.0)
Negative predictive value (%, 95% CI) 89% (83.0-92.7)
Positive likelihood ratio 26.9
Negative likelihood ratio 0.69
False-negative rate 68%
False-positive rate 1.2%
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depending on the nature of then food being tested: in particular,
there was signiﬁcant disagreement on whether to apply the food to
the inner lip or the outer lip (Figure 1). With respect to the inter-
pretation of LDC, a (subjective) itchy lip ormouthwas considered a
positive ﬁnding by 37% of respondents, erythema at the application
site by 46%, and urticaria/angioedema at the application site by
93%. Interestingly, the occurrence of urticaria away from the site of
application was considered a positive ﬁnding by fewer respondents:
74% if on the face but away from the application site, and 70% if
present on the body. There was also signiﬁcant variation in inter-
preting outcomes fromLDC: 17%and 31%would not proceed to a
formal OFC in the presence of oral itch or local erythema, respec-
tively, in contrast to more objective symptoms where most
respondents would stop the challenge test and interpret LDC as
indicative of food allergy (Table I).
Diagnostic performance of LDC in relation to OFC
outcomes
Two hundred twenty children were prospectively recruited for
the study, 22 of whom were excluded because of an inconclusiveOFC outcome, leaving 198 for analysis. Patients’ demographic
characteristics are presented in Table II. Twelve children had a
positive LDC: 10 with objective skin symptoms at the applica-
tion site, 1 with facial urticaria, and another who developed
generalized urticaria. The OFC was positive in 31 cases,
including 10 cases of anaphylaxis with lower respiratory symp-
toms. Ten of these 31 children (2 of 10 anaphylaxis reactions)
had a positive LDC to egg (2), cow’s milk (1), peanut (1), cashew
(2), hazelnut (1), salmon (1), chickpea (1), and prawn (1). In
these children with both a positive LDC and OFC, 5 reacted to
the top dose (w3 g protein) while 3 reacted to the ﬁrst dose of
the OFC. Two children with positive LDCs went on to have a
negative diagnostic OFC (one to egg, the other to sardine ﬁsh),
giving a false-discovery rate (the probability of a false positive if
LDC is positive) of 17% (2 of 12). Diagnostic characteristics of
the LDC are presented in Table III. There were no signiﬁcant
associations between LDC outcome and age (P ¼ .17), skin
prick test result (P ¼ .053), having atopic dermatitis (P ¼ .58),
the particular food tested (P ¼ .80), or in those with a positive
OFC, the eliciting dose (P ¼ .88) or the occurrence of
anaphylaxis (P ¼ .24) (see Table E2 in this article’s Online
Repository at www.jaci-inpractice.org).
DISCUSSION
Our data indicate that LDCs are used by most UK pediatric
allergy centers as part of their food challenge protocols, despite a
lack of evidence on their diagnostic value. We found wide
variation in how LDCs are performed and interpreted by health
care professionals, which raises major concerns about the
reproducibility and the validity of the test. We subsequently
evaluated the diagnostic utility of LDCs in a representative
clinical cohort, and demonstrated a relatively poor correlation
between the outcome of the LDC and the OFC itself.
In our cohort, a positive LDC was uncommon, even in those
cases with a positive OFC. Thus, the sensitivity of LDC is low.
Where LDC was positive, this was associated with a low false-
positive rate and a high positive likelihood ratio, although we
observed 2 cases where LDC was positive but participants went
on to tolerate the food being tested at OFC, without reaction.
These observations lead us to question the value of LDC in
clinical practice, especially given the concerns regarding hetero-
geneity in test performance and interpretation: a high positive
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tients likely to be clinically allergic (and therefore already have a
high pretest probability),13 while the false-discovery rate (17% in
our cohort) despite the use of objective criteria to assess LDC
implies a need to proceed to OFC irrespective of LDC outcome.
Our ﬁndings with respect to false-positive LDC are consistent
with the observations of Hourihane et al.6 Venter et al14 also
assessed the diagnostic utility of LDC, and found that all 9 of 13
patients with a positive LDC also had a positive OFC; however,
4 children did not proceed to formal food challenge. Both Rance
and Dutau4 and ourselves observed children who developed
systemic symptoms following LDC; thus, the same safety mea-
sures should be in place for LDC as for routine OFC. It is
therefore difﬁcult to see how incorporating LDC before OFC
might be cost-effective, given the low positive rate and the pre-
cautions required because of risk of systemic reaction. In addi-
tion, the inclusion of LDC prolongs the challenge test
unnecessarily. We used objective criteria consistent with the
PRACTALL consensus to determine the outcome of OFC, in
contrast to previous studies. We therefore believe that our data
provide evidence against the use of LDC during OFC and
certainly as an alternative to OFC, due to relatively poor diag-
nostic utility (in part because of a lack of clarity over test
interpretation), as well as the potential for systemic reactions.
Although our prospective assessment of LDC was limited by
cohort size, our data are representative of children undergoing
OFC in routine clinical practice, and our sample size is probably
typical of the number of food challenges that may be undertaken
by a medium-to large-size allergy service over a 1-year period. For
example, a large tertiary allergy service in the United States
undertook an average of 230 OFCs per annum, although this
cohort had a positive OFC rate of 30%.15 The lower rate of
positive OFC in our cohort implies a lower risk proﬁle to
included cases. Thus, the diagnostic characteristics of LDC
generated in this study cannot necessarily be applied elsewhere,
and although our cohort was sufﬁciently powered to assess
speciﬁcity (and thus rate of false positives), we were underpow-
ered to estimate sensitivity/positive predictive value as indicated
by the lower precision of the estimates as seen in the 95% CIs for
sensitivity/positive predictive value in Table III. In routine
practice, outside the context of desensitization, OFCs are
generally performed in patients in whom the degree of sensiti-
zation is less than that which predicts 95% likelihood of reaction.
However, OFCs are increasingly undertaken in children with a
higher likelihood of clinical allergy—for example, before the
commencement of oral immunotherapy. In this context, it is
possible that the false-positive rate would be slightly lower,
although this does not negate the signiﬁcance of a false-positive
LDC as observed in this study. We would not recommend
LDC as part of OFC before initiating oral immunotherapy,
because in this context one should deﬁne an eliciting dose (which
then allows response to treatment to be assessed) and not depend
on LDC that is clearly associated with a false-positive rate.
Recent research has provided evidence for the earlier intro-
duction of potential food allergens into the infant diet, to reduce
the risk of developing food allergy.16 Although the associated
guidelines do not suggest LDC,17 in our experience many health
care professionals recommend LDC as an initial step in intro-
ducing foods such as peanut butter into the infant diet. Wecaution against this approach, given the lack of evidence in the
literature and the false-discovery rate identiﬁed in this study.
In conclusion, current guidelines should counsel against the use
of LDC in the diagnosis of IgE-mediated food allergy, because
there is no robust evidence that LDC is useful for diagnosis.
Finally, units continuing to perform LDC either as part of routine
protocols or at parental request should interpret any positive
ﬁndings with care and preferably proceed to a routine OFC.
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5.e1 VAZQUEZ-ORTIZ ETALONLINE REPOSITORYTABLE E1. Questions used in this survey and responses obtained
Question Response options Responses obtained, n (%)
Q1. Please select your main role as a health professional. Dietitian 9 (5.7)
Medical doctor 92 (58.2)
Nurse/nurse practitioner 51 (32.3)
Other 6 (3.8)
Q2. A. If you are a dietitian, in what area of dietetics do
you work?
General dietetics 0 (0)
Pediatric dietetics 5 (55.6)
Specialist allergy dietetics 4 (44.4)
Other 0 (0)
Q2. B. If you are a doctor, please select which option
best describes your medical practice.
Specialist in allergy/immunology 41 (44.6)
Adult physician (hospital based) 6 (6.6)
General pediatrics 39 (42.4)
General practice 4 (4.4)
Other 2 (2)
Q2.C. If you are a nurse, please select the option which
best describes your area of practice.
Specialist allergy nurse 41 (80.4)
Pediatrics 8 (15.7)
Adult nursing 2 (3.9)
Community nurse/nurse in
general practice
0 (0)
Other 0 (0)
Q3. Do you work in A tertiary specialist allergy clinic 67 (48)
District general hospital 63 (49.6)
Primary care facility 3 (2.4)
Q4. For how many years have you been performing food
challenges yourself?
Over 10 y 56 (37.1)
5-10 y 46 (30.5)
Under 5 y 37 (24.5)
I am still in training 12 (8)
Q5. The patients I see are All pediatric patients 100 (86.7)
Mostly pediatric but some adult
patients
7 (4.7)
About half pediatric and half
adult patients
2 (1.3)
Mostly adult but some pediatric
patients
17 (11.3)
All adult 24 (16)
Q6. How many food challenges does your unit perform
every month, on average?
<5 per month 41 (28)
5-10 32 (21.9)
10-25 33 (22.6)
25-50 26 (17.8)
More than 50 14 (9.6)
Q7. Do you think “lip doses” are useful as a ﬁrst step in
performing a food challenge?
Yes 101 (69.7)
No 33 (22.8)
Not sure 11 (7.6)
Q8. Do you (or your unit) ever use lip doses when doing
a food challenge?
Yes 117 (80.7)
Never 28 (19.3)
(continued)
TABLE E1. (Continued)
Question Response options Responses obtained, n (%)
Q9. How do you perform a lip dose to cow’s milk? Apply a drop to the inner lip 49 (45)
Apply a drop to the outer lip 48 (44)
Other 12 (11)
Q10. How do you perform a lip dose to peanut? Apply a smear of peanut butter to
the inner lip
15 (13.8)
Apply a smear of peanut butter to
the outer lip
19 (17.4)
Rub some peanut on the inner lip 37 (33.9)
Rub some peanut on the outer lip 29 (29.6)
Other 9 (8.3)
Q11. How do you perform a lip dose to cashew nut? Rub some cashew on the inner lip 50 (48.3)
Rub some cashew on the outer lip 48 (44.4)
Other 10 (9.3)
Q12. What do you consider to be a positive lip dose (tick
all that apply)?
Patient complains of itchy lip or
mouth
38 (36.5)
Redness or erythema at the site of
application of dose
48 (46.2)
Urticaria and/or swelling at the
site of application
97 (93.3)
Urticaria/angioedema on the face,
but away from the site of
application
77 (74)
Urticaria on the body 73 (70.2)
Q13-17. If the following symptoms occurred to a lip
dose, what would you do?
Q13. Patient complains of itchy lip or mouth STOP the challenge, ie, not
proceed to an oral dose
18 (17.3)
CONTINUE with the challenge,
ie, proceed to an oral dose
86 (82.7)
Q14. Redness or erythema at the site of application of
dose
STOP the challenge, ie, not
proceed to an oral dose
32 (30.8)
CONTINUE with the challenge,
ie, proceed to an oral dose
72 (69.2)
Q15. Urticaria and/or swelling at the site of
application
STOP the challenge, ie, not
proceed to an oral dose
91 (87.5)
CONTINUE with the challenge,
ie, proceed to an oral dose
13 (12.5)
Q16. Urticaria/angioedema on the face, but away from
the site of application
STOP the challenge, ie, not
proceed to an oral dose
97 (93.3)
CONTINUE with the challenge,
ie, proceed to an oral dose
7 (6.7)
Q17. Urticaria on the body STOP the challenge, ie, not
proceed to an oral dose
97 (93.3)
CONTINUE with the challenge,
ie, proceed to an oral dose
7 (6.7)
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TABLE E2. Comparative analysis between children with positive and negative LDCs (N ¼ 198)
Characteristic
LDC result
P valuePositive Negative
Age (y), median 3.0 6.0 .17
Atopic dermatitis, n (%) 6 (50) 64 (34) .58
Skin prick test (mm), median 3 2 .053
Food tried at challenge, n (%) .80
Tree nuts 3 (25) 58 (31)
Peanut 1 (8) 32 (17)
Egg 3 (25) 30 (16)
Fish 2 (16.7) 18 (10)
Cow’s milk 1 (8) 11 (6)
Prawn/shrimp 0 (0) 7 (4)
Other 2 (17) 30 (16)
Anaphylaxis at OFC (where OFC positive) 2 of 10 (20) 8 of 21 (38) .24
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